-
3
-
-
0026295126
-
Differences and similarities in the diagnosis and treatment of Graves' disease in Europe, Japan, and the United States
-
Wartofsky L, Glinoer D, Solomon B, Nagataki S, Lagasse R, Nagayama Y, et al. Differences and similarities in the diagnosis and treatment of Graves' disease in Europe, Japan, and the United States. Thyroid 1991;1:129-35.
-
(1991)
Thyroid
, vol.1
, pp. 129-135
-
-
Wartofsky, L.1
Glinoer, D.2
Solomon, B.3
Nagataki, S.4
Lagasse, R.5
Nagayama, Y.6
-
4
-
-
33745998461
-
The cost effectiveness of treatment modalities for thyrotoxicosis in a U.K. center
-
6
-
Patel NN, Abraham P, Buscombe J, Vanderpump MP. The cost effectiveness of treatment modalities for thyrotoxicosis in a U.K. center. Thyroid 2006;16(6):593-8.
-
(2006)
Thyroid
, vol.16
, pp. 593-598
-
-
Patel, N.N.1
Abraham, P.2
Buscombe, J.3
Vanderpump, M.P.4
-
7
-
-
34347388660
-
Radioiodine treatment for benign thyroid diseases
-
6
-
Weetman AP. Radioiodine treatment for benign thyroid diseases. Clin Endocrinol (Oxf) 2007;66(6):757-64.
-
(2007)
Clin Endocrinol (Oxf)
, vol.66
, pp. 757-764
-
-
Weetman, A.P.1
-
8
-
-
34347267317
-
Increased cardiovascular and cancer mortality after radioiodine treatment for hyperthyroidism
-
6
-
Metso S, Jaatinen P, Huhtala H, Auvinen A, Oksala H, Salmi J. Increased cardiovascular and cancer mortality after radioiodine treatment for hyperthyroidism. J Clin Endocrinol Metab 2007;92(6):2190-6.
-
(2007)
J Clin Endocrinol Metab
, vol.92
, pp. 2190-2196
-
-
Metso, S.1
Jaatinen, P.2
Huhtala, H.3
Auvinen, A.4
Oksala, H.5
Salmi, J.6
-
9
-
-
34248341689
-
Increased cancer incidence after radioiodine treatment for hyperthyroidism
-
10
-
Metso S, Auvinen A, Huhtala H, Salmi J, Oksala H, Jaatinen P. Increased cancer incidence after radioiodine treatment for hyperthyroidism. Cancer 2007;109(10):1972-9.
-
(2007)
Cancer
, vol.109
, pp. 1972-1979
-
-
Metso, S.1
Auvinen, A.2
Huhtala, H.3
Salmi, J.4
Oksala, H.5
Jaatinen, P.6
-
10
-
-
34347255774
-
Cardiovascular and cancer mortality after radioiodine treatment of hyperthyroidism
-
6
-
Vanderpump M. Cardiovascular and cancer mortality after radioiodine treatment of hyperthyroidism. J Clin Endocrinol Metab 2007;92(6):2033-5.
-
(2007)
J Clin Endocrinol Metab
, vol.92
, pp. 2033-2035
-
-
Vanderpump, M.1
-
11
-
-
33947536305
-
An optimal treatment for pediatric Graves' disease is radioiodine
-
3
-
Rivkees SA, Dinauer C. An optimal treatment for pediatric Graves' disease is radioiodine. J Clin Endocrinol Metab 2007;92(3):797-800.
-
(2007)
J Clin Endocrinol Metab
, vol.92
, pp. 797-800
-
-
Rivkees, S.A.1
Dinauer, C.2
-
12
-
-
33947507758
-
The optimal treatment for pediatric Graves' disease is surgery
-
3
-
Lee JA, Grumbach MM, Clark OH. The optimal treatment for pediatric Graves' disease is surgery. J Clin Endocrinol Metab 2007;92(3):801-3.
-
(2007)
J Clin Endocrinol Metab
, vol.92
, pp. 801-803
-
-
Lee, J.A.1
Grumbach, M.M.2
Clark, O.H.3
-
13
-
-
34250317440
-
Radioiodine treatment of hyperthyroidism: Fixed or calculated doses; Intelligent design or science?
-
7
-
Sisson JC, Avram AM, Rubello D, Gross MD. Radioiodine treatment of hyperthyroidism: fixed or calculated doses; intelligent design or science? Eur J Nucl Med Mol Imaging 2007;34(7):1129-30.
-
(2007)
Eur J Nucl Med Mol Imaging
, vol.34
, pp. 1129-1130
-
-
Sisson, J.C.1
Avram, A.M.2
Rubello, D.3
Gross, M.D.4
-
15
-
-
33746638745
-
Verification of the agreement of two dosimetric methods with radioiodine therapy in hyperthyroid patients
-
8
-
Canzi C, Zito F, Voltini F, Reschini E, Gerundini P. Verification of the agreement of two dosimetric methods with radioiodine therapy in hyperthyroid patients. Med Phys 2006;33(8):2860-7.
-
(2006)
Med Phys
, vol.33
, pp. 2860-2867
-
-
Canzi, C.1
Zito, F.2
Voltini, F.3
Reschini, E.4
Gerundini, P.5
-
17
-
-
34347247625
-
Ultrasonography thyroid volume estimation in hyperthyroid patients treated with individual radioiodine dose
-
4
-
Massaro F, Vera L, Schiavo M, Lagasio C, Caputo M, Bagnasco M, et al. Ultrasonography thyroid volume estimation in hyperthyroid patients treated with individual radioiodine dose. J Endocrinol Invest 2007;30(4):318-22.
-
(2007)
J Endocrinol Invest
, vol.30
, pp. 318-322
-
-
Massaro, F.1
Vera, L.2
Schiavo, M.3
Lagasio, C.4
Caputo, M.5
Bagnasco, M.6
-
18
-
-
34548160615
-
Clinical radionuclide therapy dosimetry: The quest for the "holy Gray"
-
Jun 13; [Epub ahead of print].
-
Flux G, Bardies M, Chiesa C, Monsieurs M, Savolainen S, Strand SE, et al. Clinical radionuclide therapy dosimetry: the quest for the "Holy Gray". Eur J Nucl Med Mol Imaging 2007 Jun 13; [Epub ahead of print].
-
(2007)
Eur J Nucl Med Mol Imaging
-
-
Flux, G.1
Bardies, M.2
Chiesa, C.3
Monsieurs, M.4
Savolainen, S.5
Strand, S.E.6
-
20
-
-
34250653235
-
Patient misconceptions and ethical challenges in radioactive iodine scanning and therapy
-
3
-
Rosenthal MS. Patient misconceptions and ethical challenges in radioactive iodine scanning and therapy. J Nucl Med Technol 2006;34(3):143-50; quiz 151-2.
-
(2006)
J Nucl Med Technol
, vol.34
, pp. 143-150
-
-
Rosenthal, M.S.1
-
21
-
-
0032707075
-
Thyroid disease and its treatment: Short- and long-term consequences
-
6
-
Franklyn JA. Thyroid disease and its treatment: short- and long-term consequences. J R Coll Physicians Lond 1999;33(6):564-7.
-
(1999)
J R Coll Physicians Lond
, vol.33
, pp. 564-567
-
-
Franklyn, J.A.1
|